TR199700917T1 - Oral farmasötik dozaj formlari. - Google Patents
Oral farmasötik dozaj formlari.Info
- Publication number
- TR199700917T1 TR199700917T1 TR97/00917T TR9700917T TR199700917T1 TR 199700917 T1 TR199700917 T1 TR 199700917T1 TR 97/00917 T TR97/00917 T TR 97/00917T TR 9700917 T TR9700917 T TR 9700917T TR 199700917 T1 TR199700917 T1 TR 199700917T1
- Authority
- TR
- Turkey
- Prior art keywords
- dosage form
- oral pharmaceutical
- pharmaceutical dosage
- fixed formulation
- unit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Proton pompasi inhibitörünün enterik bir kaplama katmani ile korundugu, bir proton pompasi inhibitörü ve bir veya daha fazla prokinetik maddeden olusan, sabit formulasyona sahip oral bir farmasötik dozaj formudur. Sabit formulasyon çok katmanli tablet, kapsül, veya çok üniteli tabletlenmis dozaj formu halindedir. Çok üniteli dozaj formlari en çok tercih edilenlerdendir. Yeni sabit formulasyon özellikle gasrtoesofajeal reflü rahatsizliklarinin tedavisinde faydali olmaktadir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9600072A SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | New oral formulation of two active ingredients II |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199700917T1 true TR199700917T1 (tr) | 1997-11-21 |
Family
ID=20400970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR97/00917T TR199700917T1 (tr) | 1996-01-08 | 1996-12-20 | Oral farmasötik dozaj formlari. |
Country Status (29)
Country | Link |
---|---|
US (1) | US6132771A (tr) |
EP (1) | EP0814840B1 (tr) |
JP (1) | JPH11501949A (tr) |
KR (1) | KR100486057B1 (tr) |
CN (1) | CN1142792C (tr) |
AR (1) | AR008750A1 (tr) |
AT (1) | ATE228010T1 (tr) |
AU (1) | AU712572B2 (tr) |
BR (1) | BR9607344A (tr) |
CA (1) | CA2214033C (tr) |
CZ (1) | CZ280897A3 (tr) |
DE (1) | DE69624910T2 (tr) |
DK (1) | DK0814840T3 (tr) |
EE (1) | EE9700195A (tr) |
ES (1) | ES2185816T3 (tr) |
HU (1) | HUP9904094A3 (tr) |
ID (1) | ID18383A (tr) |
IL (1) | IL121652A (tr) |
IS (1) | IS4550A (tr) |
MX (1) | MX9706769A (tr) |
NO (1) | NO316425B1 (tr) |
NZ (1) | NZ325976A (tr) |
PL (1) | PL322176A1 (tr) |
PT (1) | PT814840E (tr) |
SE (1) | SE9600072D0 (tr) |
SK (1) | SK117097A3 (tr) |
TR (1) | TR199700917T1 (tr) |
WO (1) | WO1997025065A1 (tr) |
ZA (1) | ZA9610938B (tr) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
ES2137862B1 (es) * | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
WO1999029299A1 (en) * | 1997-12-08 | 1999-06-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel suppository form comprising an acid-labile active compound |
DK173431B1 (da) * | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
EP1121103B1 (en) | 1998-05-18 | 2006-12-20 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets comprising a benzimidazole |
DK1561458T3 (da) | 1998-07-28 | 2010-10-25 | Takeda Pharmaceutical | Hurtigt henfaldende fast middel |
SE9803772D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
CA2366768C (en) * | 1999-04-01 | 2005-05-24 | Wm. Wrigley Jr. Company | Long flavor duration releasing structures for chewing gum |
US6428809B1 (en) * | 1999-08-18 | 2002-08-06 | Microdose Technologies, Inc. | Metering and packaging of controlled release medication |
US6521255B2 (en) * | 2000-01-13 | 2003-02-18 | Osmotica Corp. | Osmotic device containing ranitidine and a prokinetic agent |
US6667057B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Levofloxacin antibiotic product, use and formulation thereof |
US6663890B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Metronidazole antibiotic product, use and formulation thereof |
US6623758B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Cephalosporin-metronidazole antibiotic composition |
US6669948B2 (en) | 2000-02-24 | 2003-12-30 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6991807B2 (en) * | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
US7025989B2 (en) * | 2000-02-24 | 2006-04-11 | Advancis Pharmaceutical Corp. | Multiple-delayed released antibiotic product, use and formulation thereof |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6638532B2 (en) | 2000-02-24 | 2003-10-28 | Advancis Pharmaceutical Corp. | Tetracycline—doxycycline antibiotic composition |
US6730320B2 (en) | 2000-02-24 | 2004-05-04 | Advancis Pharmaceutical Corp. | Tetracycline antibiotic product, use and formulation thereof |
US6632453B2 (en) | 2000-02-24 | 2003-10-14 | Advancis Pharmaceutical Corp. | Ciprofoxacin-metronidazole antibiotic composition |
US6663891B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Erythromyacin antibiotic product, use and formulation thereof |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6627222B2 (en) | 2000-02-24 | 2003-09-30 | Advancis Pharmaceutical Corp. | Amoxicillin-dicloxacillin antibiotic composition |
US6667042B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Fluroquinilone antibiotic product, use and formulation thereof |
US6610328B2 (en) | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
US6623757B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Antibiotic composition |
HUP0302631A2 (hu) | 2000-03-30 | 2003-11-28 | Bristol-Myers Squibb Co. | Stavudint tartalmazó elnyújtott hatóanyag-kibocsátású szemcsék |
US20040146554A1 (en) * | 2000-07-15 | 2004-07-29 | Sharma Virender K. | Method for the administration of acid-labile drugs |
AU2001296908A1 (en) * | 2000-09-29 | 2002-04-08 | Geneva Pharmaceuticals, Inc. | Proton pump inhibitor formulation |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US7105174B2 (en) * | 2000-10-13 | 2006-09-12 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-neoplastic product, use and formulation thereof |
US7157095B2 (en) * | 2000-10-13 | 2007-01-02 | Advancis Pharmaceutical Corporation | Multiple-delayed release antifungal product, use and formulation thereof |
US20020197314A1 (en) | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
CN100562317C (zh) | 2001-10-17 | 2009-11-25 | 武田药品工业株式会社 | 含大量酸不稳定药物的颗粒 |
JP4331930B2 (ja) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | 酸に不安定な薬物の高含量顆粒 |
JP2006282677A (ja) * | 2001-10-17 | 2006-10-19 | Takeda Chem Ind Ltd | 酸に不安定な薬物の高含量顆粒 |
JP2005521662A (ja) * | 2002-01-25 | 2005-07-21 | サンタラス インコーポレイティッド | プロトンポンプ阻害剤の経粘膜送達 |
US7125563B2 (en) | 2002-04-12 | 2006-10-24 | Dava Pharmaceuticals, Inc. | Sustained release pharmaceutical preparations and methods for producing the same |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
SE0203065D0 (sv) * | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US20040114368A1 (en) * | 2002-12-13 | 2004-06-17 | Shyu Shing Jy | Light device having rotatable or movable view |
WO2004071374A2 (en) * | 2003-02-11 | 2004-08-26 | Torrent Pharmaceuticals Limited | Once a day orally administered pharmaceutical compositions |
US20040185119A1 (en) * | 2003-02-26 | 2004-09-23 | Theuer Richard C. | Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency |
BR8300543U (pt) * | 2003-04-09 | 2004-11-23 | Medley S A Ind Farmaceutica | Embalagem, ou kit de medicamentos, ou apresentação facilitadora da administração de medicamentos por parte dos pacientes |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009365A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009368A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005011637A1 (ja) * | 2003-08-04 | 2005-02-10 | Eisai Co., Ltd. | 用時分散型製剤 |
WO2005016311A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005023184A2 (en) * | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
BRPI0414046A (pt) * | 2003-08-29 | 2006-10-24 | Dynogen Pharmaceuticals Inc | método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7767768B2 (en) * | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US8153161B2 (en) * | 2003-12-09 | 2012-04-10 | Dainippon Sumitomo Pharma Co., Ltd. | Medicament-containing particle and a solid preparation containing the particle |
AU2005204014B2 (en) * | 2004-01-06 | 2008-02-28 | Panacea Biotec Ltd. | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
WO2005123042A1 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc. | Controlled release pharmaceutical formulation |
WO2006014427A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
WO2006011638A1 (ja) * | 2004-07-28 | 2006-02-02 | Dainippon Sumitomo Pharma Co., Ltd. | 複数の被覆層を有するフィルムコーティング錠 |
AR051654A1 (es) * | 2004-11-04 | 2007-01-31 | Astrazeneca Ab | Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones |
AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
EP1830822A1 (en) * | 2004-12-24 | 2007-09-12 | LEK Pharmaceuticals D.D. | Stable pharmaceutical composition comprising an active substance in the form of solid solution |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
KR20080096779A (ko) * | 2006-01-20 | 2008-11-03 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규 필름 코팅정 |
WO2007122478A2 (en) * | 2006-04-20 | 2007-11-01 | Themis Laboratories Private Limited | Multiple unit compositions |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2007138606A2 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
WO2010096814A1 (en) * | 2009-02-23 | 2010-08-26 | Eurand, Inc. | Controlled-release compositions comprising a proton pump inhibitor |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
CA2765635C (en) * | 2009-06-25 | 2016-09-06 | Wockhardt Research Centre | Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof |
CN105343885A (zh) * | 2009-11-20 | 2016-02-24 | 汉达医药有限责任公司 | 右兰索拉唑的口服配方 |
CN105381524A (zh) | 2010-01-05 | 2016-03-09 | 微剂量治疗技术公司 | 吸入设备和方法 |
KR101143997B1 (ko) * | 2010-03-04 | 2012-05-09 | 한미사이언스 주식회사 | 유산균 제제 및 5-ht4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법 |
WO2011126327A2 (en) * | 2010-04-09 | 2011-10-13 | Hyundai Pharm Co., Ltd. | Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof |
WO2011136750A1 (en) * | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Pharmaceutical compositions inducing synergistic effect |
BRPI1103093A2 (pt) * | 2011-06-03 | 2013-07-02 | Eurofarma Laboratarios Ltda | composiÇço farmacÊutica oral e uso da composiÇço farmacÊutica oral |
EP2797600A4 (en) | 2011-12-28 | 2015-09-16 | Pozen Inc | IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID |
EP2974720B1 (en) * | 2013-03-15 | 2024-02-21 | Korea United Pharm. Inc. | Mosapride sustained-release preparation for providing pharmacological clinical effects with once-a-day administration |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
CN108289849A (zh) * | 2015-06-26 | 2018-07-17 | 韩国联合制药株式会社 | 莫沙必利与雷贝拉唑的复合制剂 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
KR102034694B1 (ko) * | 2017-12-14 | 2019-10-22 | 한국유나이티드제약 주식회사 | 모사프리드와 라베프라졸을 함유하는 유핵정 복합제제 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535031A (en) * | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
JPS5598120A (en) * | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
US4340582A (en) * | 1981-01-15 | 1982-07-20 | Abbott Laboratories | Erythromycin base tablets |
US4377568A (en) * | 1981-08-12 | 1983-03-22 | Merck Sharp & Dohme (I.A.) Corp. | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
JPS5973529A (ja) * | 1982-10-12 | 1984-04-25 | Sankyo Co Ltd | 被覆固形製剤の製造法 |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
US4518433A (en) * | 1982-11-08 | 1985-05-21 | Fmc Corporation | Enteric coating for pharmaceutical dosage forms |
GB2132887A (en) * | 1982-11-15 | 1984-07-18 | Procter & Gamble | Enteric-coated anti-inflammatory compositions |
US4556552A (en) * | 1983-09-19 | 1985-12-03 | Colorcon, Inc. | Enteric film-coating compositions |
JPH0759499B2 (ja) * | 1984-02-10 | 1995-06-28 | ベンツォン ファーマ エイ/エス | 拡散被覆された複合単位服用剤 |
US4568560A (en) * | 1984-03-16 | 1986-02-04 | Warner-Lambert Company | Encapsulated fragrances and flavors and process therefor |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5330982A (en) * | 1986-12-17 | 1994-07-19 | Glaxo Group Limited | Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
NZ235877A (en) * | 1989-11-02 | 1992-09-25 | Mcneil Ppc Inc | Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence |
JP3142919B2 (ja) * | 1991-11-06 | 2001-03-07 | 旭化成株式会社 | セルロース誘導体ラテックス及びその製法 |
US5160742A (en) * | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
JPH07509702A (ja) * | 1992-08-05 | 1995-10-26 | エフ・エイチ・フォールディング・アンド・カンパニー・リミテッド | ペレット薬剤組成物 |
US5330759A (en) * | 1992-08-26 | 1994-07-19 | Sterling Winthrop Inc. | Enteric coated soft capsules and method of preparation thereof |
JPH08512322A (ja) * | 1993-07-06 | 1996-12-24 | メルク エンド カンパニー インコーポレーテッド | H▲下2▼拮抗剤−胃腸運動性の薬剤組合せ物 |
JP3017906B2 (ja) * | 1993-10-08 | 2000-03-13 | 信越化学工業株式会社 | 腸溶性コーティング剤分散液 |
US5798120A (en) * | 1993-10-12 | 1998-08-25 | Tokyo Tanabe Company Limited | Enteric granule-containing tablets |
GB2285989A (en) * | 1994-01-28 | 1995-08-02 | Merck Frosst Canada Inc | Aqueous formulations for enteric coatings |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
MX9600857A (es) * | 1994-07-08 | 1997-06-28 | Astra Ab | Forma de dosificacion i en tabletas, con unidades multiples. |
SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
-
1996
- 1996-01-08 SE SE9600072A patent/SE9600072D0/xx unknown
- 1996-12-20 NZ NZ325976A patent/NZ325976A/xx unknown
- 1996-12-20 EP EP96944725A patent/EP0814840B1/en not_active Expired - Lifetime
- 1996-12-20 KR KR1019970706235A patent/KR100486057B1/ko not_active IP Right Cessation
- 1996-12-20 JP JP9525130A patent/JPH11501949A/ja not_active Ceased
- 1996-12-20 SK SK1170-97A patent/SK117097A3/sk unknown
- 1996-12-20 EE EE9700195A patent/EE9700195A/xx unknown
- 1996-12-20 PT PT96944725T patent/PT814840E/pt unknown
- 1996-12-20 PL PL96322176A patent/PL322176A1/xx unknown
- 1996-12-20 IL IL12165296A patent/IL121652A/en not_active IP Right Cessation
- 1996-12-20 TR TR97/00917T patent/TR199700917T1/tr unknown
- 1996-12-20 CA CA002214033A patent/CA2214033C/en not_active Expired - Fee Related
- 1996-12-20 AT AT96944725T patent/ATE228010T1/de not_active IP Right Cessation
- 1996-12-20 ES ES96944725T patent/ES2185816T3/es not_active Expired - Lifetime
- 1996-12-20 US US08/750,936 patent/US6132771A/en not_active Expired - Lifetime
- 1996-12-20 HU HU9904094A patent/HUP9904094A3/hu unknown
- 1996-12-20 CZ CZ972808A patent/CZ280897A3/cs unknown
- 1996-12-20 WO PCT/SE1996/001736 patent/WO1997025065A1/en active IP Right Grant
- 1996-12-20 DK DK96944725T patent/DK0814840T3/da active
- 1996-12-20 MX MX9706769A patent/MX9706769A/es not_active IP Right Cessation
- 1996-12-20 DE DE69624910T patent/DE69624910T2/de not_active Expired - Fee Related
- 1996-12-20 BR BR9607344A patent/BR9607344A/pt not_active IP Right Cessation
- 1996-12-20 AU AU13240/97A patent/AU712572B2/en not_active Ceased
- 1996-12-20 CN CNB96193607XA patent/CN1142792C/zh not_active Expired - Fee Related
- 1996-12-26 AR ARP960105898A patent/AR008750A1/es not_active Application Discontinuation
- 1996-12-30 ZA ZA9610938A patent/ZA9610938B/xx unknown
-
1997
- 1997-01-08 ID IDP970026A patent/ID18383A/id unknown
- 1997-08-21 IS IS4550A patent/IS4550A/is unknown
- 1997-09-04 NO NO19974070A patent/NO316425B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199700917T1 (tr) | Oral farmasötik dozaj formlari. | |
SE9600070D0 (sv) | New oral pharmaceutical dosage forms | |
SE9500422D0 (sv) | New oral pharmaceutical dosage forms | |
SE9600071D0 (sv) | New oral formulation of two active ingredients I | |
DK1037634T3 (da) | Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo) | |
TR199901417T2 (tr) | Analjezik etkisi olan yeni bilesimler. | |
NO971206D0 (no) | Forlenget-frigjöringsformulering | |
EE9700189A (et) | Mitmikühikuline kihisev annusvorm, mis sisaldab prootonpumba inhibiitorit | |
DK1685839T3 (da) | Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist | |
ATE312602T1 (de) | Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung | |
ATE514418T1 (de) | Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan | |
TR200003808T2 (tr) | Bir cox-2 inhibitörü içeren farmasötik kombinasyon | |
UY27296A1 (es) | Composición farmacéutica que contiene mosaprida y pancreatina | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
RU99118887A (ru) | Применение ингибиторов желудочно-кишечной липазы | |
NO20011217D0 (no) | Doseringsform omfattende væskeformulering | |
SE9700885D0 (sv) | New pharmaceutical formulation | |
TR199802351T2 (tr) | Topikal kullanim için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bilesimi. | |
HRP20031057B1 (hr) | Tableta koja sadrži cetirizin i pseudoefedrin | |
TR200200978T2 (tr) | Yeni mirtazapin formülasyonu | |
TR199801184T2 (tr) | Analjezik tesirli yeni bilesikler. | |
UY24780A1 (es) | Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación. | |
DK2014290T3 (da) | Anvendelse af tenatoprazol til behandling af gastroøsofageal refluks | |
SE9504267D0 (sv) | New therapeutic use | |
BR0101880A (pt) | Uma nova composição farmacêutica |